Medical Journals

Alpha2-adrenoceptor-mediated Modulation of the Release of Gaba and Noradrenaline in the Rat Substantia Nigra Pars Reticulata.

Authors:
  • Alachkar Amal
  • Brotchie Jonathan
  • Jones Owen T

From: Faculty of Life Sciences, University of Manchester, 1.124 Stopford Building, Oxford Road, Manchester M13 9PTUK.

Neuroscience letters

  • Publish Date: Mar 2006
  • ISSN: 0304-3940
  • Volume: 395
  • Issue: 2
  • Pages: 138-42
  • Medium: Print
  • Language: English
  • Citation (JAMA): Alachkar Amal, Brotchie Jonathan, Jones Owen T, et al. Alpha2-adrenoceptor-mediated Modulation of the Release of Gaba and Noradrenaline in the Rat Substantia Nigra Pars Reticulata.. Neurosci. Lett. Mar 2006;395:138-42

Abstract

The control of movement by the basal ganglia is influenced by inputs from diverse brain structures. Unfortunately, the mechanisms of modulation are poorly defined. Based on neuroanatomical evidence for alpha2A and alpha2C subtypes of alpha2 adrenergic receptors within this region, we hypothesize that noradrenergic alpha2-receptors can influence transmitter release in the SNr. To test this hypothesis we examined the effect of the alpha 2 adrenergic agonist, clonidine, and antagonist, rauwolscine, on the efflux of [3H]-GABA and [3H]-noradrenaline from brain slices of the rat substantia nigra pars reticulata. At low concentrations (10 nM), rauwolscine caused an 84.2 +/- 18.51% (p < 0.01) increase in KCl-evoked GABA release. At higher concentrations, rauwolscine caused a dose-dependent return to basal levels. Rauwolscine also enhanced basal GABA efflux after KCl washout with a similar biphasic concentration-dependence. Surprisingly, clonidine also enhanced [3H]-GABA release but had no effect on KCl-evoked [3H]-GABA release at concentrations which inhibited [3H]-NA efflux. These effects were potentiated by the GABA re-uptake inhibitor nipecotic acid. Together, our data indicate an important role for noradrenergic modulation in the SNr. The enhancing effect of both the alpha2 adrenoceptor agonist and antagonist on GABA release, while appearing paradoxical, can be rationalised by actions at distinct subsets of alpha2 adrenoceptors, using a simple model where alpha2A adrenoceptors are localized on the terminals of noradrenergic afferents impinging upon alpha2C adrenoceptor-containing GABAergic striato-nigral neurones.

Mesh Headings (Keywords): Adrenergic alpha-Agonists, Adrenergic alpha-Antagonists, Animals, Clonidine, Dose-Response Relationship, Drug, Male, Nipecotic Acids, Norepinephrine, Organ Culture Techniques, Rats, Receptors, Adrenergic, alpha-2, Substantia Nigra, Yohimbine, gamma-Aminobutyric Acid


Check for Full Text / PubMed Unique Identifier (PMID): 16356632


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.